MediFind

Find a Doctor

Robert L. Schlossman

Dana-Farber Cancer Institute, Inc.
Oncology, Hematology, Internal Medicine
Male

Bio


Robert Schlossman is an Oncologist and an Internal Medicine specialist in Boston, Massachusetts. He has been an author on 67 peer reviewed articles and participated in 1 clinical trials in the past 15 years. Dr. Schlossman's top three areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, and Schnitzler Syndrome. He is licensed to treat patients in MA.

Contact

450 Brookline Ave
M229
Boston, MA 02215, US

Latest Research


Latest Advance
Study
  • Condition: Relapsed/Refractory Multiple Myeloma (MM)
  • Journal: American journal of hematology
  • Treatment Used: CXCR4 Inhibitor Plerixafor in Combination with Bortezomib as Chemosensitization Strategy
  • Number of Patients: 58
  • Published —
This study evaluated the safety and maximal-tolerated dose (MTD) of the combination CXCR4 inhibitor plerixafor and bortezomib in patients with relapsed/refractory multiple myeloma.
Latest Advance
Study
  • Condition: Relapsed/Refractory Multiple Myeloma
  • Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
  • Treatment Used: Evofosfamide with Bortezomib
  • Number of Patients: 59
  • Published —
The study researched the outcomes of Evofosfamide with Bortezomib for patients with relapsed/refractory multiple myeloma.
Latest Advance
Study
  • Condition: Transplant-Ineligible Multiple Myeloma
  • Journal: British journal of haematology
  • Treatment Used: Modified Lenalidomide, Bortezomib, and Dexamethasone
  • Number of Patients: 53
  • Published —
This study tested the safety and efficacy of using a combination treatment of novel medicine for the treatment of multiple myeloma that was ineligible for transplantation.

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

450 Brookline Ave
M229
Boston, MA 02215, US

Credentials

  • Licenses
    Internal Medicine in MA

Insurance

Contact them to find out if they accept your insurance plan.